{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:24:43Z","timestamp":1792859083646,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejso.2025.110528","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:15:37Z","timestamp":1762330537000},"page":"110528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The association between pathological complete response and prognosis of gastric or adenocarcinoma of esophagogastric junction cancer following neoadjuvant chemotherapy: A meta-analysis"],"prefix":"10.1016","volume":"52","author":[{"given":"Yuwei","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ershuo","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panping","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8891-5736","authenticated-orcid":false,"given":"Kun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejso.2025.110528_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.ejso.2025.110528_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","article-title":"Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Ajani","year":"2022","journal-title":"J Natl Compr Cancer Netw"},{"issue":"3","key":"10.1016\/j.ejso.2025.110528_bib3","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.ejso.2025.110528_bib4","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s10555-020-09925-3","article-title":"Gastric cancer: a comprehensive review of current and future treatment strategies","volume":"39","author":"Sexton","year":"2020","journal-title":"Cancer Metastasis Rev"},{"issue":"5","key":"10.1016\/j.ejso.2025.110528_bib5","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.gassur.2004.12.002","article-title":"Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution","volume":"9","author":"Cunningham","year":"2005","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"10.1016\/j.ejso.2025.110528_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10120-006-0369-4","article-title":"Retrospective analysis of 45 consecutive patients with advanced gastric cancer treated with neoadjuvant chemotherapy using an S-1\/CDDP combination","volume":"9","author":"Satoh","year":"2006","journal-title":"Gastric Cancer"},{"issue":"10","key":"10.1016\/j.ejso.2025.110528_bib7","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ejso.2006.07.009","article-title":"Response to neoadjuvant chemotherapy and effects of tumor regression in gastric cancer","volume":"32","author":"D'Ugo","year":"2006","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110528_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10549-010-1228-x","article-title":"Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials","volume":"125","author":"von Minckwitz","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"10.1016\/j.ejso.2025.110528_bib9","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1470-2045(10)70172-8","article-title":"Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data","volume":"11","author":"Maas","year":"2010","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2025.110528_bib10","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.eururo.2013.06.049","article-title":"Correlation of pathologic complete response with survival after neoadjuvant chemotherapy in bladder cancer treated with cystectomy: a meta-analysis","volume":"65","author":"Petrelli","year":"2014","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110528_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-017-0598-5","article-title":"Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from national cancer center in China","volume":"17","author":"Zhu","year":"2017","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"10.1016\/j.ejso.2025.110528_bib12","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1177\/0003134820972083","article-title":"Pathologic complete response following neoadjuvant therapy for gastric adenocarcinoma: a national cancer database analysis on incidence, predictors, and outcomes","volume":"87","author":"Kaltenmeier","year":"2020","journal-title":"Am Surg"},{"issue":"2","key":"10.1016\/j.ejso.2025.110528_bib13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejso.2021.07.016","article-title":"Pathological complete response at the para-aortic nodes as a possible surrogate endpoint in gastric cancer surgery with para-aortic node dissection after neoadjuvant chemotherapy","volume":"48","author":"Wada","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2025.110528_bib14","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1245\/s10434-023-13728-5","article-title":"Is pathologic complete response a good predictor for the long-term, clinical outcome in patients with gastric cancer after neoadjuvant chemotherapy? A retrospective, multi-institution study in China","volume":"30","author":"Lin","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2025.110528_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2024.108343","article-title":"Impact of pCR after neoadjuvant chemotherapy and radical D2 dissection in locally advanced gastric cancers: analysis of 1001 cases","volume":"50","author":"Bhandare","year":"2024","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2025.110528_bib16","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1245\/s10434-013-3462-z","article-title":"Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?","volume":"21","author":"Heger","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110528_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/2923700","article-title":"Nomogram for predicting survival in advanced gastric cancer after neoadjuvant chemotherapy and radical surgery","volume":"2021","author":"Chen","year":"2021","journal-title":"Gastroenterol Res Pract"},{"issue":"5","key":"10.1016\/j.ejso.2025.110528_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doz078","article-title":"Association between time interval from neoadjuvant chemoradiotherapy to surgery and complete histological tumor response in esophageal and gastroesophageal junction cancer: a national cohort study","volume":"33","author":"Klevebro","year":"2020","journal-title":"Dis Esophagus"},{"issue":"3","key":"10.1016\/j.ejso.2025.110528_bib19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00000658-199903000-00001","article-title":"Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer","volume":"229","author":"Lowy","year":"1999","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.ejso.2025.110528_bib20","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1245\/s10434-019-07638-8","article-title":"Characteristics and survival of gastric cancer patients with pathologic complete response to preoperative therapy","volume":"26","author":"Stark","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2025.110528_bib21","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1093\/annonc\/mdt141","article-title":"Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapy","volume":"24","author":"Lorenzen","year":"2013","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110528_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12876-017-0598-5","article-title":"Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from national cancer center in China","volume":"17","author":"Zhu","year":"2017","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"10.1016\/j.ejso.2025.110528_bib23","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1177\/0003134820972083","article-title":"Pathologic complete response following neoadjuvant therapy for gastric adenocarcinoma: a national cancer database analysis on incidence, predictors, and outcomes","volume":"87","author":"Kaltenmeier","year":"2021","journal-title":"Am Surg"},{"issue":"2","key":"10.1016\/j.ejso.2025.110528_bib24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejso.2021.07.016","article-title":"Pathological complete response at the para-aortic nodes as a possible surrogate endpoint in gastric cancer surgery with para-aortic node dissection after neoadjuvant chemotherapy","volume":"48","author":"Wada","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2025.110528_bib25","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1245\/s10434-023-13728-5","article-title":"Is pathologic complete response a good predictor for the long-term, clinical outcome in patients with gastric cancer after neoadjuvant chemotherapy? A retrospective, multi-institution study in China","volume":"30","author":"Lin","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110528_bib26","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2147\/RMHP.S413052","article-title":"Prognostic model of D2 radical gastrectomy combined with neoadjuvant chemotherapy for gastric cancer","volume":"16","author":"Wang","year":"2023","journal-title":"Risk Manag Healthc Policy"},{"issue":"6","key":"10.1016\/j.ejso.2025.110528_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2024.108343","article-title":"Impact of pCR after neoadjuvant chemotherapy and radical D2 dissection in locally advanced gastric cancers: analysis of 1001 cases","volume":"50","author":"Bhandare","year":"2024","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110528_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejca.2017.11.020","article-title":"Histopathological regression predicts treatment outcome in locally advanced esophagogastric adenocarcinoma","volume":"90","author":"Spoerl","year":"2018","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.ejso.2025.110528_bib29","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/jso.26458","article-title":"Predictors and significance of histologic response to neoadjuvant therapy for gastric cancer","volume":"123","author":"Rajabnejad","year":"2021","journal-title":"J Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2025.110528_bib30","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/jso.26458","article-title":"Predictors and significance of histologic response to neoadjuvant therapy for gastric cancer","volume":"123","author":"Rajabnejad","year":"2021","journal-title":"J Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2025.110528_bib31","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1093\/annonc\/mdt141","article-title":"Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapy","volume":"24","author":"Lorenzen","year":"2013","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2025.110528_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3747\/co.21.1570","article-title":"Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma-a pilot study","volume":"21","author":"Orditura","year":"2014","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ejso.2025.110528_bib33","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1186\/1477-7819-12-397","article-title":"Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy","volume":"12","author":"Sun","year":"2014","journal-title":"World J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110528_bib34","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1186\/s12885-023-11508-8","article-title":"Concurrent clinical and pathological response predicts favorable prognosis of patients with gastric cancer after neoadjuvant therapy: a real-world study","volume":"23","author":"Sun","year":"2023","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.ejso.2025.110528_bib35","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1007\/s11605-020-04688-2","article-title":"Tumor regression grade in gastric cancer after preoperative therapy","volume":"25","author":"Ikoma","year":"2021","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.ejso.2025.110528_bib36","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ejso.2025.110528_bib37","author":"Wells"},{"issue":"24","key":"10.1016\/j.ejso.2025.110528_bib38","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.ejso.2025.110528_bib39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"issue":"22","key":"10.1016\/j.ejso.2025.110528_bib40","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1002\/sim.1303","article-title":"Aggregate data meta-analysis with time-to-event outcomes","volume":"21","author":"Williamson","year":"2002","journal-title":"Stat Med"},{"issue":"7414","key":"10.1016\/j.ejso.2025.110528_bib41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Bmj"},{"issue":"3","key":"10.1016\/j.ejso.2025.110528_bib42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"10","key":"10.1016\/j.ejso.2025.110528_bib43","first-page":"Ed000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the cochrane handbook for systematic reviews of interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ejso.2025.110528_bib44","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"issue":"7109","key":"10.1016\/j.ejso.2025.110528_bib45","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"Bmj"},{"issue":"19","key":"10.1016\/j.ejso.2025.110528_bib46","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.3748\/wjg.v25.i19.2338","article-title":"Role of D2 gastrectomy in gastric cancer with clinical para-aortic lymph node metastasis","volume":"25","author":"Zheng","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110528_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/srep17516","article-title":"Regional arterial infusion chemotherapy improves the pathological response rate for advanced gastric cancer with short-term neoadjuvant chemotherapy","volume":"5","author":"Wu","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejso.2025.110528_bib48","article-title":"Effects of hypoxia-inducible factor-prolyl hydroxylase inhibitors vs. erythropoiesis-stimulating agents on iron metabolism in non-dialysis-dependent anemic patients with CKD: a network meta-analysis","volume":"14","author":"Yang","year":"2023","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.ejso.2025.110528_bib49","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3747\/co.21.1570","article-title":"Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma\u2014A pilot study","volume":"21","author":"Orditura","year":"2014","journal-title":"Curr Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2025.110528_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1674","article-title":"Comprehensive multi\u2010omics analysis of resectable locally advanced gastric cancer: assessing response to neoadjuvant camrelizumab and chemotherapy in a single\u2010center, open\u2010label, single\u2010arm phase II trial","volume":"14","author":"Zhao","year":"2024","journal-title":"Clin Transl Med"},{"issue":"2","key":"10.1016\/j.ejso.2025.110528_bib51","doi-asserted-by":"crossref","first-page":"580","DOI":"10.4143\/crt.2023.812","article-title":"NESC multicenter phase II trial in the preoperative treatment of gastric adenocarcinoma with chemotherapy (Docetaxel-Cisplatin-5FU+Lenograstim) followed by chemoradiation based 5FU and oxaliplatin and surgery","volume":"56","author":"Mineur","year":"2024","journal-title":"Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.ejso.2025.110528_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7122","article-title":"Nomogram for predicting pathological response to neoadjuvant treatment in patients with locally advanced gastric cancer: data from a phase III clinical trial","volume":"13","author":"Shao","year":"2024","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.ejso.2025.110528_bib53","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.21037\/jgo.2017.08.13","article-title":"Tumor response evaluation after neoadjuvant chemotherapy in locally advanced gastric adenocarcinoma: a prospective, multi-center cohort study","volume":"8","author":"Achilli","year":"2017","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110528_bib54","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-023-11508-8","article-title":"Concurrent clinical and pathological response predicts favorable prognosis of patients with gastric cancer after neoadjuvant therapy: a real-world study","volume":"23","author":"Sun","year":"2023","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2025.110528_bib55","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-022-10125-1","article-title":"Comparison of response evaluation criteria in solid tumors and tumor regression grade in evaluating the effect of preoperative systemic therapy of gastric cancer","volume":"22","author":"Lai","year":"2022","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.ejso.2025.110528_bib56","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1007\/s11605-020-04688-2","article-title":"Tumor regression grade in gastric cancer after preoperative therapy","volume":"25","author":"Ikoma","year":"2020","journal-title":"J Gastrointest Surg"},{"issue":"11","key":"10.1016\/j.ejso.2025.110528_bib57","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C","article-title":"Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations","volume":"73","author":"Mandard","year":"1994","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ejso.2025.110528_bib58","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/cncr.11660","article-title":"Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy","volume":"98","author":"Becker","year":"2003","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ejso.2025.110528_bib59","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/SLA.0b013e318216f449","article-title":"Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases","volume":"253","author":"Becker","year":"2011","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.ejso.2025.110528_bib60","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s10120-013-0294-2","article-title":"Validity of response assessment criteria in neoadjuvant chemotherapy for gastric cancer (JCOG0507-A)","volume":"17","author":"Kurokawa","year":"2014","journal-title":"Gastric Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2025.110528_bib61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10120-011-0041-5","article-title":"Japanese classification of gastric carcinoma: 3rd English edition","volume":"14","year":"2011","journal-title":"Gastric Cancer"},{"issue":"10","key":"10.1016\/j.ejso.2025.110528_bib62","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.5858\/133.10.1539","article-title":"Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum","volume":"133","author":"Washington","year":"2009","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.ejso.2025.110528_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189294","article-title":"Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: a meta-analysis","volume":"13","author":"Li","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ejso.2025.110528_bib64","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1470-2045(23)00541-7","article-title":"Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study","volume":"25","author":"Shitara","year":"2024","journal-title":"Lancet Oncol"},{"issue":"23","key":"10.1016\/j.ejso.2025.110528_bib65","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1200\/JCO.2015.65.7692","article-title":"Effect of pathologic tumor response and nodal status on survival in the medical research council adjuvant gastric infusional chemotherapy trial","volume":"34","author":"Smyth","year":"2016","journal-title":"J Clin Oncol"},{"issue":"10294","key":"10.1016\/j.ejso.2025.110528_bib66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ejso.2025.110528_bib67","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10120-022-01286-w","article-title":"A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer","volume":"25","author":"Hasegawa","year":"2022","journal-title":"Gastric Cancer"},{"issue":"15_suppl","key":"10.1016\/j.ejso.2025.110528_bib68","article-title":"Phase II study of perioperative toripalimab in combination with FLOT in patients with locally advanced resectable gastric\/gastroesophageal junction (GEJ) adenocarcinoma","volume":"39","author":"Li","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2025.110528_bib69","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3389\/fonc.2019.01320","article-title":"VESTIGE: adjuvant immunotherapy in patients with resected esophageal, gastroesophageal junction and gastric cancer following preoperative chemotherapy with high risk for recurrence (N+ and\/or R1): an open label randomized controlled Phase-2-Study","volume":"9","author":"Smyth","year":"2019","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2025.110528_bib70","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/1097-0142(197410)34:4<1278::AID-CNCR2820340440>3.0.CO;2-F","article-title":"Areas of failure found at reoperation (second or symptomatic look) following \"curative surgery\" for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy","volume":"34","author":"Gunderson","year":"1974","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ejso.2025.110528_bib71","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.18457","article-title":"Global incidence and mortality of gastric cancer, 1980-2018","volume":"4","author":"Wong","year":"2021","journal-title":"JAMA Netw Open"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325009564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325009564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T07:57:29Z","timestamp":1767945449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325009564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0748798325009564"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110528","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between pathological complete response and prognosis of gastric or adenocarcinoma of esophagogastric junction cancer following neoadjuvant chemotherapy: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110528","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110528"}}